[Pathophysiology, diagnosis, and therapy for the management of acquired clotting factor deficiency]
- PMID: 38185529
- PMCID: PMC10753255
- DOI: 10.3760/cma.j.issn.0253-2727.2023.11.014
[Pathophysiology, diagnosis, and therapy for the management of acquired clotting factor deficiency]
Figures
Similar articles
-
The old and new: PCCs, VIIa, and long-lasting clotting factors for hemophilia and other bleeding disorders.Hematology Am Soc Hematol Educ Program. 2013;2013:44-51. doi: 10.1182/asheducation-2013.1.44. Hematology Am Soc Hematol Educ Program. 2013. PMID: 24319161 Review.
-
Pharmacovigilance for plasma-derived clotting factor concentrates.Lancet. 1993 Dec 11;342(8885):1489. doi: 10.1016/0140-6736(93)92967-x. Lancet. 1993. PMID: 7902506 No abstract available.
-
[Fresh plasma and concentrates of clotting factors for therapy of perioperative coagulopathy: what is known?].Anaesthesist. 2006 Sep;55(9):926, 928-36. doi: 10.1007/s00101-006-1038-z. Anaesthesist. 2006. PMID: 16721605 Review. German.
-
[Rational substitution therapy in blood coagulation disorders].Infusionsther Klin Ernahr. 1980 Aug;7(4):190-4. Infusionsther Klin Ernahr. 1980. PMID: 7191414 German.
-
Therapeutic approaches to factor X deficiency with emphasis on the use of a new clotting-factor concentrate (Konyne).J Lab Clin Med. 1971 Jan;77(1):23-32. J Lab Clin Med. 1971. PMID: 5540427 No abstract available.